Simplex Trading’s CG Oncology CGON Stock Holding History

Simplex Trading’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-264	Closed	-$9.26K	–	8586
2024 Q2	$8K	Buy	+264	New	+$9.15K	﹤0.01%	7556

Other funds holding CGON

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Simplex Trading's CGON Position: Q3 2024 in Review

Simplex Trading sold out of CG Oncology (CGON) in Q3 2024, closing a stake of 264 shares — an estimated $9.26K sold.

Simplex Trading first reported a position in CGON in Q2 2024 and held it in 1 quarter. The position peaked at $8K in Q2 2024. 121 funds tracked by Wall St. Rank hold CGON as of Q3 2024.

Simplex Trading reported no remaining CG Oncology position as of Q3 2024 after selling out during the quarter.
Simplex Trading sold 264 CG Oncology shares in Q3 2024, an estimated $9.26K.
Simplex Trading first reported a position in CG Oncology in Q2 2024 and held it in 1 quarter.
Simplex Trading's CG Oncology position peaked at $8K in Q2 2024.
121 funds tracked by Wall St. Rank held CG Oncology as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.